New Zealand markets close in 5 hours 11 minutes

Well Lead Medical Co., Ltd. (603309.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
12.82+0.10 (+0.79%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 3.76B
Enterprise value 3.76B
Trailing P/E 19.72
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.81
Price/book (mrq)2.01
Enterprise value/revenue 2.81
Enterprise value/EBITDA 15.84

Trading information

Stock price history

Beta (5Y monthly) -0.22
52-week change 3-28.94%
S&P500 52-week change 325.38%
52-week high 319.78
52-week low 38.52
50-day moving average 311.37
200-day moving average 312.79

Share statistics

Avg vol (3-month) 34.42M
Avg vol (10-day) 36.37M
Shares outstanding 5293.16M
Implied shares outstanding 6293.16M
Float 8141.77M
% held by insiders 157.50%
% held by institutions 19.54%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.34
Forward annual dividend yield 42.65%
Trailing annual dividend rate 30.50
Trailing annual dividend yield 33.93%
5-year average dividend yield 41.31
Payout ratio 452.31%
Dividend date 3N/A
Ex-dividend date 429 May 2023
Last split factor 21.3:1
Last split date 325 May 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 14.28%
Operating margin (ttm)20.59%

Management effectiveness

Return on assets (ttm)5.17%
Return on equity (ttm)10.82%

Income statement

Revenue (ttm)1.34B
Revenue per share (ttm)4.55
Quarterly revenue growth (yoy)-14.50%
Gross profit (ttm)N/A
EBITDA 271.19M
Net income avi to common (ttm)190.64M
Diluted EPS (ttm)0.65
Quarterly earnings growth (yoy)-3.50%

Balance sheet

Total cash (mrq)663.8M
Total cash per share (mrq)2.26
Total debt (mrq)662.97M
Total debt/equity (mrq)35.09%
Current ratio (mrq)1.77
Book value per share (mrq)6.37

Cash flow statement

Operating cash flow (ttm)193.24M
Levered free cash flow (ttm)-279.81M